21 U.S.C. § 902
Savings provisions
Nothing in this chapter, except this part and, to the extent of any inconsistency, sections 827(e) and 829 of this title, shall be construed as in any way affecting, modifying, repealing, or superseding the provisions of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. § 301 et seq.].
Notes of Decisions
Cited in 2
cases (1 in the last 5 years), 1976–2025 · leading case: Advanced Integrative Med. Sci. Inst., Pllc v. United States Drug Enf't Admin, 128 F.4th 1133 (9th Cir. 2025).
Advanced Integrative Med. Sci. Inst., Pllc v. United States Drug Enf't Admin, 128 F.4th 1133 (9th Cir. 2025). “” 21 U.S.C. § 902 . AIMS also represented that “DEA has permitted access to schedule I substances in similar circumstances throughout its history,” citing DEA’s “support[ing] physician-initiated therapeutic use of a schedule I cannabis-derived experimental drug,” the seizure…”
Am. Pharm. Ass'n v. David Mathews, 530 F.2d 1054 (D.C. Cir. 1976). “See § 707 of Title II of the Controlled Substances Act, 21 U.S.C. § 902 (1970): Nothing in this chapter .”
Annotations are extracted automatically from the opinions in the
Syfert caselaw corpus and ranked by authority, recency, and
treatment. Dots show Syfertize treatment of the citing case itself.